About: MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases in dermatology and rheumatology, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.
Sector: Healthcare
Industry: Biotechnology
Latest price: $15.01 (-1.19%)
MLTXNASDAQMoonLake Immunotherapeutics
MoonLake Immunotherapeutics share price
MLTX price activity
Last Price
$15.010
Change (24hr)
-0.18 USD (-1.19%)
Volume
1.43M
Volume (4w avg)
-
Open
$15.06
Day Range
$14.87 - $15.24
Previous Close
$15.19
Last Trade
04 Sep, 10:08 pm GMT+0
Delayed
04 Sep, 10:08 pm GMT+0
MLTX price performance
Delayed
04 Sep, 10:08 pm GMT+0
MLTX Market Signals